7:30 am - 7:45 am

Industry Sponsored Short Snapper Session #1-C

TNF Inhibitors: Still have a good place in treatment armamentarium for IBD with adalimumab and infliximab improved biosimilars

Dr. Jason Reinglas MD FRCPC completed his MD degree as well as his Internal Medicine and Gastroenterology residencies at the University of Ottawa. Dr. Reinglas then completed an advanced IBD fellowship in Montreal at McGill University. He is currently the medical director of the Scarborough Center for Inflammatory Bowel Disease and NKS Infusion (Scarborough site).  Dr. Reinglas has authored over 30 published manuscripts and abstracts, one book chapter and has presented at many local and international conferences. His interests include improving access to care for IBD patients in the community and capsule endoscopy.